摘要
新型冠状病毒肺炎(COVID-19)等突发重大公共卫生事件严重威胁人类生命健康。国家药品抽检是药品质量监管的重要手段,在打击假冒伪劣药品,保障公众用药安全方面发挥重要作用。通过梳理国家药品抽检情况,总结COVID-19疫情中的工作状况,分析下一步面临的形势,建议扬长避短,因势利导,加强工作防护,优先抽检防控用药,关注严重风险,严打假劣药品,及时信息公开,以便在突发重大公共卫生事件阻击战中更好发挥药品抽检的作用。
The major public health emergencies,such as Corona Virus Disease 2019(COVID-19),seriously threaten human health.National drug sampling and testing is an important method for drug quality supervision,which plays an important role in fighting against counterfeit and inferior drugs and ensuring the safety of drugs used by the public.In the paper,the overall situation of the national drug sampling and testing was introduced,the current situation during the COVID-19 epidemic was summarized,and the future situation was analyzed.It was suggested to strengthen work protection,prioritize the sampling of epidemic-related drugs,pay attention to serious drug risks,crack down on counterfeit and inferior drugs,and disclose information in a timely manner,so as to play better roles of drug sampling and testing in major public health emergencies.
作者
刘文
朱炯
王翀
Liu Wen;Zhu Jiong;Wang Chong(National Institute for Food and Drug Control,Beijing 102629,China)
出处
《中国药师》
CAS
2020年第9期1820-1822,共3页
China Pharmacist
关键词
突发重大公共卫生事件
新型冠状病毒肺炎
国家药品抽检
Major public health emergencies
Corona Virus Disease 2019
National drug sampling and testing
